BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19549382)

  • 1. [Effect of demethylation treatment on the expression of inhibitory receptor KIR gene in NK-92MI cell line].
    Gao XN; Lin J; Wang LL; Gao L; Jin HJ; Sun JF; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):656-60. PubMed ID: 19549382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of demethylating treatment on cytotoxicity of NK-92MI cells].
    Gao XN; Wang LL; Lin J; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):924-8. PubMed ID: 19698230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.
    Moesta AK; Norman PJ; Yawata M; Yawata N; Gleimer M; Parham P
    J Immunol; 2008 Mar; 180(6):3969-79. PubMed ID: 18322206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantity of HLA-C surface expression and licensing of KIR2DL+ natural killer cells.
    Charoudeh HN; Schmied L; Gonzalez A; Terszowski G; Czaja K; Schmitter K; Infanti L; Buser A; Stern M
    Immunogenetics; 2012 Oct; 64(10):739-45. PubMed ID: 22772778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
    Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
    J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.
    Hilton HG; Vago L; Older Aguilar AM; Moesta AK; Graef T; Abi-Rached L; Norman PJ; Guethlein LA; Fleischhauer K; Parham P
    J Immunol; 2012 Aug; 189(3):1418-30. PubMed ID: 22772445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-C and KIR genes in hepatitis C virus infection.
    Montes-Cano MA; Caro-Oleas JL; Romero-Gómez M; Diago M; Andrade R; Carmona I; Aguilar Reina J; Núñez-Roldán A; González-Escribano MF
    Hum Immunol; 2005 Nov; 66(11):1106-9. PubMed ID: 16571411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition.
    Schönberg K; Sribar M; Enczmann J; Fischer JC; Uhrberg M
    Blood; 2011 Jan; 117(1):98-107. PubMed ID: 20935255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
    David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
    J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Killer immunoglobulin-like receptor gene genotype and expression pattern in NK-92MI and K562 cells].
    Dou LP; DA WM; Liu JH; Sun JF; Zhao Y; Wang QS; Gao CJ; Yu L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Sep; 25(9):767-9. PubMed ID: 19737456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.
    Borgerding A; Hasenkamp J; Engelke M; Burkhart N; Trümper L; Wienands J; Glass B
    Exp Hematol; 2010 Mar; 38(3):213-21. PubMed ID: 20056126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Promoter methylation regulates KIR3DL1 gene expression in NK-92MI cell line].
    Gao XN; Yu L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jul; 24(7):668-71. PubMed ID: 18616907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
    Guo KY; Mei JZ; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals.
    Legrand N; David G; Rodallec A; Gaultier A; Salmon D; Cesbron A; Wittkop L; Raffi F; Gendzekhadze K; Retière C; Allavena C; Gagne K
    Clin Exp Immunol; 2021 Apr; 204(1):107-124. PubMed ID: 33314121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIR downregulation by IL-12/15/18 unleashes human NK cells from KIR/HLA-I inhibition and enhances killing of tumor cells.
    Ewen EM; Pahl JHW; Miller M; Watzl C; Cerwenka A
    Eur J Immunol; 2018 Feb; 48(2):355-365. PubMed ID: 29105756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligand.
    Frazier WR; Steiner N; Hou L; Dakshanamurthy S; Hurley CK
    J Immunol; 2013 Jun; 190(12):6198-208. PubMed ID: 23686481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
    Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide selectivity discriminates NK cells from KIR2DL2- and KIR2DL3-positive individuals.
    Cassidy S; Mukherjee S; Myint TM; Mbiribindi B; North H; Traherne J; Mulder A; Claas FH; Purbhoo MA; Das J; Khakoo SI
    Eur J Immunol; 2015 Feb; 45(2):492-500. PubMed ID: 25359276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution and survival of marine carnivores did not require a diversity of killer cell Ig-like receptors or Ly49 NK cell receptors.
    Hammond JA; Guethlein LA; Abi-Rached L; Moesta AK; Parham P
    J Immunol; 2009 Mar; 182(6):3618-27. PubMed ID: 19265140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.
    Gao X; Jiao Y; Wang L; Liu X; Sun W; Cui B; Chen Z; Zhao Y
    Clin Immunol; 2010 Oct; 137(1):139-46. PubMed ID: 20643584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.